FR2872702B3 - Systeme de delivrance - Google Patents
Systeme de delivranceInfo
- Publication number
- FR2872702B3 FR2872702B3 FR0413770A FR0413770A FR2872702B3 FR 2872702 B3 FR2872702 B3 FR 2872702B3 FR 0413770 A FR0413770 A FR 0413770A FR 0413770 A FR0413770 A FR 0413770A FR 2872702 B3 FR2872702 B3 FR 2872702B3
- Authority
- FR
- France
- Prior art keywords
- delivery system
- vaginal cavity
- internal phase
- high internal
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B2017/4216—Operations on uterus, e.g. endometrium
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58627304P | 2004-07-08 | 2004-07-08 | |
PCT/US2004/022058 WO2006016869A1 (fr) | 2004-07-08 | 2004-07-08 | Système de délivrance |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2872702A3 FR2872702A3 (fr) | 2006-01-13 |
FR2872702B3 true FR2872702B3 (fr) | 2006-06-02 |
Family
ID=35787422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0413770A Expired - Lifetime FR2872702B3 (fr) | 2004-07-08 | 2004-12-22 | Systeme de delivrance |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1765452A4 (fr) |
CN (2) | CN102188375A (fr) |
AU (2) | AU2004100776A4 (fr) |
BR (1) | BRPI0513066A (fr) |
CA (1) | CA2572919A1 (fr) |
CZ (1) | CZ15068U1 (fr) |
ES (1) | ES1060042Y (fr) |
FR (1) | FR2872702B3 (fr) |
MX (2) | MXPA04007681A (fr) |
NL (1) | NL1026978C1 (fr) |
NZ (1) | NZ552406A (fr) |
RU (1) | RU2379027C2 (fr) |
WO (2) | WO2006016869A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2008651A1 (fr) * | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | Patch bioérodable |
EP2100632A1 (fr) | 2008-03-11 | 2009-09-16 | Pantarhei Devices B.V. | Dispositif d'applicateur pour cavité du corps |
US8308678B2 (en) | 2008-09-23 | 2012-11-13 | Mcneil-Ppc, Inc. | Pre-filled applicator device |
EP2359750A1 (fr) | 2010-02-15 | 2011-08-24 | Delphi Bioscience B.V. | Dispositif d'analyse doté d'une valve |
FR2968004B1 (fr) | 2010-11-29 | 2013-06-28 | Sojasun Technologies | Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines. |
RU2538703C2 (ru) * | 2013-03-12 | 2015-01-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения вагинального кандидоза и способ ее получения |
CN108671366A (zh) * | 2015-09-18 | 2018-10-19 | 赵坚 | 一种外用妇科药的施药装置 |
KR102509239B1 (ko) * | 2018-06-11 | 2023-03-14 | 더 프록터 앤드 갬블 캄파니 | 질 병태를 치료하기 위한 방법 및 어플리케이터 |
CN112716796B (zh) * | 2018-12-11 | 2022-07-08 | 管云 | 助力配药器 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4636202A (en) * | 1984-07-27 | 1987-01-13 | Syntex (U.S.A.) Inc. | Medicament applicator with plunger assembly and automatically-openable closure therefor |
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
ES2133090B1 (es) * | 1997-02-21 | 2000-04-01 | Uriach & Cia Sa J | Nuevo aplicador para la administracion de medicaciones semisolidas. |
US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
US20040047910A1 (en) * | 2000-07-07 | 2004-03-11 | Christian Beckett | Suppository and composition comprising at least one polyethylene glycol |
-
2004
- 2004-07-08 MX MXPA04007681A patent/MXPA04007681A/es unknown
- 2004-07-08 WO PCT/US2004/022058 patent/WO2006016869A1/fr active Application Filing
- 2004-08-03 CZ CZ200415701U patent/CZ15068U1/cs not_active IP Right Cessation
- 2004-09-06 NL NL1026978A patent/NL1026978C1/nl not_active IP Right Cessation
- 2004-09-09 ES ES200402091U patent/ES1060042Y/es not_active Expired - Fee Related
- 2004-09-15 AU AU2004100776A patent/AU2004100776A4/en not_active Expired
- 2004-12-22 FR FR0413770A patent/FR2872702B3/fr not_active Expired - Lifetime
-
2005
- 2005-07-08 CA CA002572919A patent/CA2572919A1/fr not_active Abandoned
- 2005-07-08 NZ NZ552406A patent/NZ552406A/en not_active IP Right Cessation
- 2005-07-08 RU RU2007104782/14A patent/RU2379027C2/ru not_active IP Right Cessation
- 2005-07-08 EP EP05769226A patent/EP1765452A4/fr not_active Withdrawn
- 2005-07-08 WO PCT/US2005/024200 patent/WO2006014572A1/fr active Application Filing
- 2005-07-08 AU AU2005269844A patent/AU2005269844A1/en not_active Abandoned
- 2005-07-08 MX MX2007000109A patent/MX2007000109A/es active IP Right Grant
- 2005-07-08 BR BRPI0513066-2A patent/BRPI0513066A/pt not_active IP Right Cessation
- 2005-07-08 CN CN2011101190673A patent/CN102188375A/zh active Pending
- 2005-07-08 CN CNA2005800002434A patent/CN1771023A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ552406A (en) | 2010-07-30 |
ES1060042Y (es) | 2005-11-01 |
EP1765452A4 (fr) | 2012-11-28 |
CZ15068U1 (cs) | 2005-01-31 |
BRPI0513066A (pt) | 2008-04-22 |
WO2006014572A1 (fr) | 2006-02-09 |
FR2872702A3 (fr) | 2006-01-13 |
RU2007104782A (ru) | 2008-08-20 |
WO2006016869A1 (fr) | 2006-02-16 |
EP1765452A1 (fr) | 2007-03-28 |
ES1060042U (es) | 2005-07-16 |
AU2005269844A1 (en) | 2006-02-09 |
MXPA04007681A (es) | 2006-01-12 |
CA2572919A1 (fr) | 2006-02-09 |
NL1026978C1 (nl) | 2006-01-10 |
RU2379027C2 (ru) | 2010-01-20 |
CN1771023A (zh) | 2006-05-10 |
MX2007000109A (es) | 2007-03-26 |
AU2004100776A4 (en) | 2004-11-18 |
CN102188375A (zh) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1765452A4 (fr) | Système d"administration | |
BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
MX2018012163A (es) | Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirr olidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina- 1-carboxamida. | |
BR0316157A (pt) | Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina | |
ATE466604T1 (de) | Medizinische vorrichtung zur verabreichung therapeutischer wirkstoffe über unterschiedliche zeitabschnitte | |
TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
SG10201805552PA (en) | Sodium channel modulators for the treatment of pain and diabetes | |
BRPI0418029A (pt) | formulação de anticorpos cd40 e métodos | |
BR112019006228A2 (pt) | tratamento de câncer de próstata | |
MX2007004861A (es) | Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias. | |
MX2010004373A (es) | Materiales miscibles en agua no acuosos como vehiculos para suministro de farmacos. | |
MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
BRPI0415232A (pt) | uso de xenÈnio com hipotermia para tratar asfixia neonatal | |
ECSP066836A (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis | |
PT1220676E (pt) | Prevencao do cancro colorrectal | |
MY142098A (en) | Delivery system | |
BRPI0918593A2 (pt) | composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente | |
BR112022003419A2 (pt) | Forma de dosagem oral sólida compreendendo naproxeno e vitamina b12 | |
MX2021003030A (es) | Composiciones farmaceuticas adecuadas para suministro articular y su uso en tratamiento de dolor de articulacion. | |
BRPI0509305A (pt) | uso de um sensibilizador insulìnico, composição farmecêutica, e , kit | |
AR028611A1 (es) | Sistema terapcutico transcutrneo con reduccion de la tendencia a la cristalizacinn de sustancia activa | |
AR044067A1 (es) | Combinaciones de principio activo y terapias para combatir el abuso de alcohol | |
BR112022003570A2 (pt) | Forma de dosagem oral sólida compreendendo naproxeno e vitamina b6 | |
UY28771A1 (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis. |